Search for: "Arthrex Inc"
Results 1 - 20
of 248
Sort by Relevance
|
Sort by Date
17 Jun 2024, 11:15 am
Arthrex, Inc., while there were some mechanisms for review of decisions by Patent Trial and Appeal Board (PTAB) panels, Director Review (DR) as a standalone review mechanism was essentially non-existent. [read post]
17 Jun 2024, 11:15 am
Arthrex, Inc., while there were some mechanisms for review of decisions by Patent Trial and Appeal Board (PTAB) panels, Director Review (DR) as a standalone review mechanism was essentially non-existent. [read post]
16 Jun 2024, 10:00 pm
Arthrex, Inc. , while there were some mechanisms for review of decisions by Patent Trial and Appeal Board panels, Director Review (DR) as a standalone review mechanism was essentially nonexistent. [read post]
16 Jun 2024, 10:00 pm
Arthrex, Inc. , while there were some mechanisms for review of decisions by Patent Trial and Appeal Board panels, Director Review (DR) as a standalone review mechanism was essentially nonexistent. [read post]
16 Jun 2024, 10:00 pm
Arthrex, Inc. , while there were some mechanisms for review of decisions by Patent Trial and Appeal Board panels, Director Review (DR) as a standalone review mechanism was essentially nonexistent. [read post]
16 Jun 2024, 10:00 pm
Arthrex, Inc. , while there were some mechanisms for review of decisions by Patent Trial and Appeal Board panels, Director Review (DR) as a standalone review mechanism was essentially nonexistent. [read post]
16 Jun 2024, 10:00 pm
Arthrex, Inc. , while there were some mechanisms for review of decisions by Patent Trial and Appeal Board panels, Director Review (DR) as a standalone review mechanism was essentially nonexistent. [read post]
16 Jun 2024, 10:00 pm
Arthrex, Inc. , while there were some mechanisms for review of decisions by Patent Trial and Appeal Board panels, Director Review (DR) as a standalone review mechanism was essentially nonexistent. [read post]
15 Apr 2024, 2:33 pm
Arthrex, Inc., 141 S. [read post]
1 Apr 2024, 11:55 am
Arthrex, Inc. , 141 S. [read post]
5 Mar 2024, 10:23 am
Pfizer Inc. v. [read post]
18 Jan 2024, 9:26 am
Citing its recent rulings on this issue in Arthrex, Inc. v. [read post]
17 Jan 2024, 5:04 am
The parties’ briefing in Loper Bright and Relentless[1] has utterly ignored statutory sections—and one section in particular—that are crucial for understanding both why the government should lose these cases and, more importantly, why the Chevron doctrine[2] cannot and should not survive in an era of textualism. [read post]
5 Dec 2023, 9:01 pm
., Inc. v. [read post]
30 Nov 2023, 12:45 pm
[Serial-blogging my recent article in the Notre Dame Law Review] On Monday, I started serial-blogging my article, The Myth of the Federal Private Nondelegation Doctrine, which has just come out in the Notre Dame Law Review. [read post]
29 Nov 2023, 8:41 am
The Federal Circuit rejected this argument based on dicta in Thryv, Inc. v. [read post]
25 Oct 2023, 4:29 pm
Arthrex, Inc., which held that, under Article II of the Constitution, decisions issued by certain inferior officers exercising adjudicatory authority must be subject to review by a politically accountable official, such as an officer appointed by the President with the advice and consent of the Senate. [read post]
10 Oct 2023, 8:56 am
Arthrex, Inc., the Supreme Court held that, under Article II of the Constitution, decisions issued by certain inferior officers exercising adjudicatory authority must be subject to review by a politically accountable official, such as an officer appointed by the President with the advice and consent of the Senate. [read post]
4 Oct 2023, 7:54 am
Arthrex, Inc., 141 S. [read post]
3 Oct 2023, 10:21 am
Further reading: Arthrex, Inc. v. [read post]
